NR - decision on Rizaport by April 2019https://www.intelgenx.com/investors/press-releases/press-release-details/2018/IntelGenx-Announces-FDAs-Acceptance-of-Resubmission-of-New-Drug-Application-for-RIZAPORT/default.aspx
resubmission due to additional info for 3rd party mfg and packaging/labelling